新生犊牛接种牛呼吸道疾病疫苗在牛病毒性腹泻病毒与溶血曼海姆菌双重攻毒下的效果
本研究将初乳喂养的奶牛与肉牛杂交犊牛在约30日龄时分为三组:组1接种含改良活牛病毒性腹泻病毒1型和2型、牛疱疹病毒1型、牛副流感3型病毒、牛呼吸道合胞病毒及溶血曼海姆菌类毒素的佐剂注射疫苗;组2同时接种鼻内温度敏感型牛疱疹病毒1型、牛呼吸道合胞病毒、牛副流感3型病毒及含改良活牛病毒性腹泻病毒1型和2型与溶血曼海姆菌类毒素的注射疫苗;组3接种安慰剂。接种约150天后经鼻内以牛病毒性腹泻病毒1b攻毒,7天后经气管内以溶血曼海姆菌攻毒,攻毒后6天安乐死。结果显示组1在牛病毒性腹泻病毒攻毒后血清抗体升高、干扰素γ反应较高、牛病毒性腹泻病毒载量较低、肺炎组织比例最低(1.6%),优于组2和组3。
要点
- 组1接种佐剂注射疫苗后牛病毒性腹泻病毒1型和2型血清抗体升高,组2和组3抗体下降。
- 组1的牛病毒性腹泻病毒载量在白细胞层和鼻样本中低于组2和组3(p<0.01)。
- 组1肺炎组织比例最低(1.6%),组2为3.7%,组3为5.3%。
核心结论
- 在母源抗体存在下接种佐剂注射疫苗对牛病毒性腹泻病毒与溶血曼海姆菌双重攻毒的保护效果优于鼻内疫苗联合注射佐剂牛病毒性腹泻病毒和溶血曼海姆菌联合疫苗的方案。
研究设计与样本
- 初乳喂养的奶牛与肉牛杂交犊牛在约30日龄时分为三组:组1接种含改良活牛病毒性腹泻病毒1型和2型、牛疱疹病毒1型、牛副流感3型病毒、牛呼吸道合胞病毒及溶血曼海姆菌类毒素的佐剂注射疫苗;组2同时接种鼻内温度敏感型牛疱疹病毒1型、牛呼吸道合胞病毒、牛副流感3型病毒及含改良活牛病毒性腹泻病毒1型和2型与溶血曼海姆菌类毒素的注射疫苗;组3接种安慰剂。接种约150天后经鼻内以牛病毒性腹泻病毒1b攻毒,7天后经气管内以溶血曼海姆菌攻毒,攻毒后6天安乐死。
主要发现
- 牛病毒性腹泻病毒感染后所有组临床症状相似。
- 组2和组3在第3天直肠温度升高,组3在第8-13天直肠温度升高。
- 组1在牛病毒性腹泻病毒感染后出现轻度白细胞减少,组2和组3白细胞减少更明显。
- 组1接种后牛病毒性腹泻病毒1型和2型血清抗体升高,组2和组3抗体下降。
- 组2和组3的白细胞层和鼻样本中牛病毒性腹泻病毒载量高于组1(p<0.01)。
关键数值与推荐
- 组1肺炎组织比例为1.6%,组2为3.7%,组3为5.3%。
- 组2和组3的白细胞层和鼻样本牛病毒性腹泻病毒载量高于组1(p<0.01)。
- 组1干扰素γ反应高于组2和组3(p<0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bovine respiratory disease is the greatest threat to calf health. In this study, colostrum-fed dairy X beef calves were vaccinated at ∼30 days of age with an adjuvanted parenteral vaccine containing modified live bovine viral diarrhea virus (BVDV) type 1 and type 2, bovine herpesvirus 1 (BHV-1), bovine parainfluenza type 3 virus (PI3V) and bovine respiratory syncytial virus (BRSV) andM. haemolyticatoxoid (Group 1), or intranasal temperature-sensitive BHV-1, BRSV and PI3V concurrently witha parenteral vaccine containing modified live BVDV type 1 and type 2 andM. haemolyticatoxoid (Group 2) or a placebo (Group 3). The calves were challenged ∼150 days post vaccination intranasally with BVDV 1b and then 7 days later intratracheally withM. haemolytica. The calves wereeuthanized 6 days after theM. haemolyticachallenge. Clinical signs following BVDV infection were similar in all groups. There was increased rectal temperatures in the Groups 2 and 3 on day 3 and in Group 3 on days 8-13. Group 1 animals had a slight leukopenia following BVDV infection while Groups 2 and 3 had greater leukopenia. BVDV type 1 and 2 serum titers increased in Group 1 following vaccination while these titers waned in Groups 2 and 3. There were higher levels of BVDV in the buffy coats and nasal samples in Group 2 and Group 3 versus Group 1 (p < 0.01). Interferon-gamma response was higher (p < 0.01) in Group 1 animals than Groups 2 and 3. Group 1 had the lowest percent pneumonic tissue (1.6%) while Group 2 vaccinates had 3.7% and the control Group 3 was 5.3%. Vaccination in the face of maternal antibody with a parenteral adjuvanted vaccine resulted in better protection than the regimen of an intranasal vaccine anda parenteral adjuvanted BVDV andM haemolyticacombination vaccine in a BVDV-M. haemolyticadual challenge.
引用
- Perkins-Oines S, Dias N, Krafsur G, et al. The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica. Vaccine. 2023. PMID: 37045678. doi:10.1016/j.vaccine.2023.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。